Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Kapp

Showing results (401-410 of 416) with videos related to

Pageof 42
Sort By:
Gynecologic Oncology|December 5, 2019
Clinical calculator predictive of chemotherapy benefit in stage 1A uterine papillary serous cancersD P Mysona, L K H Tran, P M H Tran, et al.
Gynecologic Oncology|June 24, 2019
Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patientsKatherine C Fuh, James J Java, John K Chan, et al.
Gynecologic Oncology|October 16, 2022
The clinical and prognostic significance of pre-chemotherapy serum CA-125 in high-risk early stage ovarian cancer: An NRG/GOG ancillary studyJohn K Chan, Chunqiao Tian, Joshua P Kesterson, et al.
Gynecologic Oncology|December 22, 2023
Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer - An NRG/GOG studyJohn K Chan, Chunqiao Tian, Joshua P Kesterson, et al.
Cancers|March 13, 2024
Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer<sup>®</sup>-Accredited Facilities in the United StatesCollin A Sitler, Chunqiao Tian, Chad A Hamilton, et al.
JAMA Network Open|May 15, 2025
Long-Term Survival in Patients With Low-Risk Cervical Cancer After Simple, Modified, or Radical HysterectomyChristopher M Tarney, Chunqiao Tian, Leslie M Randall, et al.
Leukemia|June 24, 2017
DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemiaV I Gaidzik, D Weber, P Paschka, et al.
Gynecologic Oncology|December 14, 2023
Underrepresentation of racial and ethnic minority groups in gynecologic oncology: An analysis of over 250 trialsMichael T Richardson, Danika Barry, Jecca R Steinberg, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 12, 2006
Uterine cancersBenjamin E Greer, Wui-Jin Koh, Nadeem Abu-Rustum, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 13, 2008
Cervical cancerBenjamin E Greer, Wui-Jin Koh, Nadeem Abu-Rustum, et al.
Pageof 42

Showing results (401-410 of 416) with videos related to

Sort By:
Pageof 42
Gynecologic Oncology|December 5, 2019
Clinical calculator predictive of chemotherapy benefit in stage 1A uterine papillary serous cancersD P Mysona, L K H Tran, P M H Tran, et al.
Gynecologic Oncology|June 24, 2019
Differences in presentation and survival of Asians compared to Caucasians with ovarian cancer: An NRG Oncology/GOG Ancillary study of 7914 patientsKatherine C Fuh, James J Java, John K Chan, et al.
Gynecologic Oncology|October 16, 2022
The clinical and prognostic significance of pre-chemotherapy serum CA-125 in high-risk early stage ovarian cancer: An NRG/GOG ancillary studyJohn K Chan, Chunqiao Tian, Joshua P Kesterson, et al.
Gynecologic Oncology|December 22, 2023
Preoperative and pre-chemotherapy CA-125 levels in high-risk early-stage ovarian cancer - An NRG/GOG studyJohn K Chan, Chunqiao Tian, Joshua P Kesterson, et al.
Cancers|March 13, 2024
Immuno-Molecular Targeted Therapy Use and Survival Benefit in Patients with Stage IVB Cervical Carcinoma in Commission on Cancer<sup>®</sup>-Accredited Facilities in the United StatesCollin A Sitler, Chunqiao Tian, Chad A Hamilton, et al.
JAMA Network Open|May 15, 2025
Long-Term Survival in Patients With Low-Risk Cervical Cancer After Simple, Modified, or Radical HysterectomyChristopher M Tarney, Chunqiao Tian, Leslie M Randall, et al.
Leukemia|June 24, 2017
DNMT3A mutant transcript levels persist in remission and do not predict outcome in patients with acute myeloid leukemiaV I Gaidzik, D Weber, P Paschka, et al.
Gynecologic Oncology|December 14, 2023
Underrepresentation of racial and ethnic minority groups in gynecologic oncology: An analysis of over 250 trialsMichael T Richardson, Danika Barry, Jecca R Steinberg, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 12, 2006
Uterine cancersBenjamin E Greer, Wui-Jin Koh, Nadeem Abu-Rustum, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 13, 2008
Cervical cancerBenjamin E Greer, Wui-Jin Koh, Nadeem Abu-Rustum, et al.
Pageof 42